“Long-term Safety and Efficacy of Belzutifan in Von Hippel–Lindau Syndrome: A VHL Coordinating Care Center Experience” (2025) Journal of Kidney Cancer, 12(3), pp. 25–31. doi:10.15586/jkcvhl.v12i3.425.